1. Market Research
  2. > Business Services
  3. > Research and Development Market Trends
  4. > Molplex Ltd. - Product Pipeline Review - 2015

Molplex Ltd. - Product Pipeline Review - 2015

  • August 2015
  • -
  • Global Markets Direct
  • -
  • 23 pages

Molplex Ltd. - Product Pipeline Review - 2015


Global Markets Direct’s, ‘Molplex Ltd. - Product Pipeline Review - 2015’, provides an overview of the Molplex Ltd.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Molplex Ltd.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


- The report provides brief overview of Molplex Ltd. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Molplex Ltd.’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Molplex Ltd.’s pipeline products

Reasons to buy

- Evaluate Molplex Ltd.’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Molplex Ltd. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Molplex Ltd.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Molplex Ltd. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Molplex Ltd.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Molplex Ltd. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

Table Of Contents

Molplex Ltd. - Product Pipeline Review - 2015
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Molplex Ltd. Snapshot 4
Molplex Ltd. Overview 4
Key Information 4
Key Facts 4
Molplex Ltd. - Research and Development Overview 5
Key Therapeutic Areas 5
Molplex Ltd. - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Molplex Ltd. - Pipeline Products Glance 9
Molplex Ltd. - Early Stage Pipeline Products 9
Discovery Products/Combination Treatment Modalities 9
Molplex Ltd. - Drug Profiles 10
Small Molecule for Infectious Mononucleosis 10
Product Description 10
Mechanism of Action 10
RandD Progress 10
Small Molecules for Autoimmune Disorders 11
Product Description 11
Mechanism of Action 11
RandD Progress 11
Small Molecules for Bone Lesions 12
Product Description 12
Mechanism of Action 12
RandD Progress 12
Small Molecules for Dengue 13
Product Description 13
Mechanism of Action 13
RandD Progress 13
Small Molecules for Diffuse Large B Cell Lymphoma 14
Product Description 14
Mechanism of Action 14
RandD Progress 14
Small Molecules for Gram-Positive Bacterial Infections 15
Product Description 15
Mechanism of Action 15
RandD Progress 15
Small Molecules for Head and Neck Cancer Squamous Cell Carcinoma 16
Product Description 16
Mechanism of Action 16
RandD Progress 16
Small Molecules for Oncology 17
Product Description 17
Mechanism of Action 17
RandD Progress 17
Molplex Ltd. - Pipeline Analysis 18
Molplex Ltd. - Pipeline Products by Route of Administration 18
Molplex Ltd. - Pipeline Products by Molecule Type 19
Molplex Ltd. - Dormant Projects 20
Molplex Ltd. - Locations And Subsidiaries 21
Head Office 21
Appendix 22
Methodology 22
Coverage 22
Secondary Research 22
Primary Research 22
Expert Panel Validation 22
Contact Us 22
Disclaimer 23

List of Tables
Molplex Ltd., Key Information 4
Molplex Ltd., Key Facts 4
Molplex Ltd. - Pipeline by Indication, 2015 6
Molplex Ltd. - Pipeline by Stage of Development, 2015 7
Molplex Ltd. - Monotherapy Products in Pipeline, 2015 8
Molplex Ltd. - Discovery, 2015 9
Molplex Ltd. - Pipeline by Route of Administration, 2015 18
Molplex Ltd. - Pipeline by Molecule Type, 2015 19
Molplex Ltd. - Dormant Developmental Projects,2015 20

List of Figures
Molplex Ltd. - Pipeline by Top 10 Indication, 2015 6

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Integrin Alpha 7 (ITGA7) - Pipeline Review, H2 2016

Integrin Alpha 7 (ITGA7) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • August 2016
  • by Global Markets Direct

Integrin Alpha 7 (ITGA7) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Integrin Alpha 7 (ITGA7) - Pipeline Review, H2 2016’, provides in depth analysis on Integrin Alpha 7 (ITGA7) ...

Cognitive Impairment - Pipeline Review, H2 2016

Cognitive Impairment - Pipeline Review, H2 2016

  • $ 2 000
  • Company report
  • September 2016
  • by Global Markets Direct

Cognitive Impairment - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Cognitive Impairment - Pipeline Review, H2 2016’, provides an overview of the Cognitive Impairment pipeline landscape. ...

CrystalGenomics, Inc. - Product Pipeline Review - 2016

CrystalGenomics, Inc. - Product Pipeline Review - 2016

  • $ 1 500
  • Company report
  • August 2016
  • by Global Markets Direct

CrystalGenomics, Inc. - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘CrystalGenomics, Inc. - Product Pipeline Review, 2016’, provides an overview of the CrystalGenomics, Inc.’s ...


Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.